label: Modified Overall Immune Related Response Criterion, Progressive Disease
label_lc: modified overall immune related response criterion, progressive disease
description: "The evaluation of the antitumor response shows that the sum of the longest diameters of target and new measurable lesions increases by at least 20% (compared to nadir), and is confirmed by repeated, consecutive observations at least 4 weeks (normally done at 6 weeks) from the date first documented."